383 filings
Page 18 of 20
EFFECT
BNTX
BioNTech SE
6 Feb 20
Notice of effectiveness
12:15am
6-K
BNTX
BioNTech SE
3 Feb 20
BioNTech Announces Commencement of Public Offering
5:19pm
F-1
BNTX
BioNTech SE
3 Feb 20
Registration statement (foreign)
4:34pm
CORRESP
BNTX
BioNTech SE
3 Feb 20
Correspondence with SEC
12:00am
CORRESP
BNTX
BioNTech SE
3 Feb 20
Correspondence with SEC
12:00am
SEC STAFF
BNTX
BioNTech SE
29 Jan 20
SEC staff action: Order
12:00am
SEC STAFF
BNTX
BioNTech SE
29 Jan 20
SEC staff action: Order
12:00am
UPLOAD
BNTX
BioNTech SE
28 Jan 20
Letter from SEC
12:00am
6-K
BNTX
BioNTech SE
27 Jan 20
6-K Corporate Presentation Jan 2020 Updated
4:45pm
DRS
BNTX
BioNTech SE
27 Jan 20
Draft registration statement
12:00am
425
Neon Therapeutics, Inc.
23 Jan 20
Business combination disclosure
4:03pm
SC 13D
Neon Therapeutics, Inc.
23 Jan 20
Neon Therapeutics, Inc.
4:01pm
425
BNTX
BioNTech SE
16 Jan 20
Business combination disclosure
5:22pm
425
BNTX
BioNTech SE
16 Jan 20
Business combination disclosure
8:51am
6-K
BNTX
BioNTech SE
16 Jan 20
BioNTech to acquire Neon to
8:47am
6-K
BNTX
BioNTech SE
15 Jan 20
6-K Ugur JPM Corporate Presentation
10:07am
6-K
BNTX
BioNTech SE
13 Jan 20
Form 6K Corporate Presentation Update Jan 2020
11:05am
6-K
BNTX
BioNTech SE
13 Jan 20
BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion
8:07am
6-K
BNTX
BioNTech SE
2 Jan 20
BioNTech Announces Publication of Preclinical Data for first-in-kind CAR-T Cell Therapy Approach Targeting Solid Tumors in Science
4:23pm
6-K
BNTX
BioNTech SE
17 Dec 19
6-K Press Release Eib Loan
7:08am